XFOR - X4 Pharmaceuticals says CEO Paula Ragan sells 239.4K shares
2023-11-06 12:12:03 ET
More on X4 Pharmaceuticals
- X4: De-Risking By WHIM Indication, Promising Potential For Expansion To Larger Market
- X4 submits New Drug Application to FDA for WHIM syndrome drug
- Seeking Alpha’s Quant Rating on X4 Pharmaceuticals
For further details see:
X4 Pharmaceuticals says CEO Paula Ragan sells 239.4K shares